The global urolithiasis management devices market is experiencing a steady rise due to the growing occurrence of kidney stones. The market is predicted to touch US$1.78 bn by 2024, rising at a CAGR of 4.50% CAGR between 2016 and 2024. The global urolithiasis management devices market is predicted to grow due to the changing lifestyles, obesity, and aging giving rise to kidney stones in human beings. In addition, the launch of numerous non-invasive treatment methods in the market have also positively impacted the development of the market. Furthermore, the decreasing duration of treatment and effective results have also shifted the preference of patients toward cutting-edge technology methods for treating kidney stones, thus boosting market growth.
Extracorporeal Lithotripters Lead Global Urolithiasis Management Devices Market
In terms of device type, the market is segmented into shockwave lithotripter and ureterorenoscopes. Shockwave lithotripter is further segmented into intracorporeal lithotripters and extracorporeal lithotripter. The segment of intracorporeal lithotripters is further segmented into laser lithotripter, pneumatic lithotripter and ultrasound lithotripter. On the other hand, the segment of ureterorenoscopes is segmented into flexible ureterorenoscopes, semi-rigid ureterorenoscopes, and rigid ureterorenoscopes. Of these, the segment of shockwave lithotripter holds a dominant share in the market, while extracorporeal lithotripter is the market leader. On the other hand, the segment of flexible ureterorenoscopes and laser lithotripters are poised to experience the highest growth rate over the forecast period.
Growing Preference toward Urolithiasis Surgeries to Boost Utilization of Urolithiasis Management Devices in Clinics
The key end users in the urolithiasis management devices market are hospitals, clinics, and ambulatory surgery centers (ASCs). Of these, in 2015, the segment of clinics held a dominant share in the market, on the basis of both volume and revenue, and is predicted to lead the market all through the forecast period. On the basis of revenue, this segment constituted a share of more than 55% in the market in the same year. The reasons for the superiority of this segment include the exponential increase in the count of individuals preferring urolithiasis surgeries and developments in treatment options that have lowered the duration of treatments.
Increasing Kidney Stones Awareness through Government Campaigns to Bolster Market Growth in North America
Geographically, the global urolithiasis management devices market is segmented into Asia Pacific, North America, Europe, the Middle East and Africa, and Latin America. Amongst these, North America held a significant share of 36% in the market in 2015. This is due to the increasing number of campaigns by governments raising the awareness regarding kidney stones in this region. In addition, the increasing aging population and the growing occurrence of kidney stones will also drive the growth of the market in this region. On the other hand, the Asia Pacific urolithiasis management devices market is anticipated to grow at a 4.60% CAGR from 2016 to 2024 owing to the increasing aging population in this region.
Browse the full Global Urolithiasis Management Devices Market report http://www.mrrse.com/urolithiasis-management-devices-market
The prominent players operating in the global urolithiasis management devices market are Allengers Medical Systems Ltd, C. R. Bard, Inc., Cook Group, Inc., Dornier Medtech GmbH, DirexGroup, Karl Storz, Boston Scientific Corporation, Olympus Corporation, Siemens Healthcare, and Electro Medical Systems S.A.